Registration - Amendment

SQUIRE PATTON BOGGS for BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to health policy proposals generally.

LobbyistCovered position, as disclosed
JENNIFER BELL New LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04

Taxation/Internal Revenue Code TAX

Issues related to health policy proposals generally.

LobbyistCovered position, as disclosed
JENNIFER BELL New LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04

Health Issues HCR

Issues related to health policy proposals generally.

LobbyistCovered position, as disclosed
JENNIFER BELL New LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04

Medicare/Medicaid MMM

Issues related to health policy proposals generally.

LobbyistCovered position, as disclosed
JENNIFER BELL New LegAsst,JohnThune00-02;HltPolAdv,SenFinCmtee03-04

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
BOEHRINGER INGELHEIM GMBH Germany Germany 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.